Category - AI/Machine learning

Broad Institute and Verily partner with Microsoft to accelerate the next generation of the Terra platform for health and life science research

Multiyear partnership brings together advanced technology, industry expertise and scale to help researchers interpret an unprecedented amount of biomedical data and derive insights to advance the treatment of human...read more

2020 Was Not Just About COVID-19

Certainly, the coronavirus and, with that COVID-19, has dominated 2020 and massively impacted not only our daily lives, but also the medical health care community and healthcare facilities in particular. Genomics proved...read more

Tempus Announces $200 Million Series G-2 Financing

December 10, 2020 Tempus, a leader in artificial intelligence and precision medicine, today announced an additional $200 million financing at a post-money valuation of $8.1 billion dollars, and an additional $250...read more

DNASTAR Integrates Genomenon Mastermind Database for Human Variant Analysis

Varian Medical Systems Invests in COTA, Inc. to Help Drive Faster, More Accurate Data-Driven Cancer Care

PALO ALTO, Calif., Nov. 10, 2020 /PRNewswire/ — Varian (NYSE: VAR) today announced a new $10M investment and collaboration agreement with COTA, Inc., a Boston-based curator...read more

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform

Scientific Knowledge Discovery Platform Pioneer, Eagle Genomics, Closes $9M in Scale-Up Funding as Major Brands Home in on the Microbiome Megatrend

Fabric Genomics Launches GEM Algorithm to Accelerate Genetic Disease Diagnosis, Provide Comprehensive Clinical-Decision Support

Seven Bridges Advances Workflow Automation Capabilities to Make Complex Multi-Omic Analysis More Accessible to Broader Mix of Users

Freenome Closes $270 Million Series C Financing to Advance Novel Multiomics Blood Testing Platform for Early Cancer Detection

Atomwise Raises $123 Million in Series B Financing Co-Led by B Capital Group and Sanabil

Guardant Health Guardant360® CDx First FDA-Approved Liquid Biopsy for Comprehensive Tumor Mutation Profiling Across All Solid Cancers

Genuity Science Announces Strategic Collaboration with Nashville Biosciences

%d bloggers like this:

Category - AI/Machine learning

Tempus Announces $200 Million Series G-2 Financing

DNASTAR Integrates Genomenon Mastermind Database for Human Variant Analysis

Varian Medical Systems Invests in COTA, Inc. to Help Drive Faster, More Accurate Data-Driven Cancer Care

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform

Scientific Knowledge Discovery Platform Pioneer, Eagle Genomics, Closes $9M in Scale-Up Funding as Major Brands Home in on the Microbiome Megatrend

Fabric Genomics Launches GEM Algorithm to Accelerate Genetic Disease Diagnosis, Provide Comprehensive Clinical-Decision Support

Large-Scale Study Shows Guardant360 Liquid Biopsy Accelerates Clinical Trial Enrollment Compared to Tissue Biopsy

Sophia Genetics Raises $110 Million In Oversubscribed New Funding Round

Sema4 Announces Collaboration with Janssen on Optimizing Oncology Clinical Trials

Illumina to Acquire GRAIL to Launch New Era of Cancer Detection

Tempus and LabCorp Announce Collaboration to Accelerate Clinical Trial Patient Participation

GRAIL Announces Filing of Registration Statement for Proposed Initial Public Offering

ClinSpec Dx receive £2.4m funding boost

Freenome Closes $270 Million Series C Financing to Advance Novel Multiomics Blood Testing Platform for Early Cancer Detection

Atomwise Raises $123 Million in Series B Financing Co-Led by B Capital Group and Sanabil

Guardant Health Guardant360® CDx First FDA-Approved Liquid Biopsy for Comprehensive Tumor Mutation Profiling Across All Solid Cancers

Genuity Science Announces Strategic Collaboration with Nashville Biosciences

Follow Me

Most popular

Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)

Pacific Biosciences and Invitae to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform

Personal Genome Diagnostics and QIAGEN Collaborate to Offer Integrated Genomic Testing and Interpretation Support

The Promise and Hope of RNA-based vaccines for COVID-19

Delfi Diagnostics Announces $100 Million Series A Financing to Develop a New Class of Early Detection Liquid Biopsy for Multiple Cancers

NuProbe Closes $42M Fundraising

Helix® Laboratory Platform Granted the First and Only FDA Authorization for a Whole Exome Sequencing Platform

QIAGEN Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute

Pharmacogenetic and Genealogy Pioneers Merge for Historic Partnership

Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure

Most discussed

Genohm Aims to Hit the Sweet Spot With a Customizable SLIMS + ELN Solution for Lab Information Management

Just Released – Our New Clinical NGS Process Report

Genomenon’s Automated Genomic Search Engine Mastermind Illuminates Current Trends in Genomic Literature – A Look at the Top Cited Variants Across the Scientific Literature

The JP Morgan Healthcare Conference from Afar

Immunotherapy and the Basis of Neoantigen Biology: Part I Neoantigens

Nebula Genomics’ Goal Is To Make The Value of Genome Sequencing a Reality

The Life of a Genetic Counselor: Providing Patient Education, Navigating Insurance, and Challenges in Choosing Tests

Review of Emerging 2018 Genomic Variants – a Genomenon Research Report

PMWC 2016 Silicon Valley: Scalable Clinical Data Interpretation The Biggest Bottleneck